Open Angle Glaucoma Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Examine DelveInsight | Nicox Ophthalmics, Sun Pharma Advanced Research Company Limited (SPARC), Visiox Pharma, TearClear, Glaukos Corporation, Ono Pharmaceutic

DelveInsight's "Open Angle Glaucoma Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Open Angle Glaucoma, historical and forecasted epidemiology as well as the Open Angle Glaucoma market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Open Angle Glaucoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Open Angle Glaucoma Market Forecast
https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Open Angle Glaucoma Market Report:
• The Open Angle Glaucoma market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
• In the 7MM, there were 17,280,267 cases of glaucoma overall in 2022. During the projected period (2023-2032), this number is expected to rise at a significant CAGR
• In the 7MM, there were 7,322,693 cases of diagnosed prevalent glaucoma in 2022. During the study period (2019-2032), there is predicted to be a considerable compound annual growth rate (CAGR) of these cases
• With 2,251,283 cases estimated to be the highest diagnosed prevalence of Open Angle Glaucoma (OAG) in the US in 2022, it is anticipated that this number will rise sharply in the near future as a result of improving diagnostic tests and population growth.
• In 2022, Japan had 1,484,947 diagnosed cases of prevalent Open Angle Glaucoma (OAG), a number that is expected to increase by the end of 2032
• There are many medications available currently for open angle glaucoma treatment. Among the most prominent medications for this indication are iDoseTR, NCX 470, PDP-716, AGN-193408, and a few more. Current clinical studies and ongoing research could alter the industry.
• Key Open Angle Glaucoma Companies: Nicox Ophthalmics, Sun Pharma Advanced Research Company Limited (SPARC), Visiox Pharma, TearClear, Glaukos Corporation, Ono Pharmaceutical, Santen Pharmaceuticals, Omikron Italia S.r.l., OPIS Spain, D. Western Therapeutics Institute (DWTI), Ocular Therapeutix, Inc., MediPrint Ophthalmics (formerly Leo Lens Pharma), Tarsier Pharma, Peregrine Ophthalmic, Ocuphire Pharma, Qlaris Bio, Inc., Betaliq, Inc., VivaVision Biotech, Inc., Abbvie, and others
• Key Open Angle Glaucoma Therapies: NCX-470, PDP-716 (Brimonidine Tartrate Ophthalmic Suspension), TC-002 (latanoprost), iDose TR (Travoprost Intraocular Implant), Sepetaprost/DE-126/ONO-9054/STN-1012600, Catioprost/DE-130A/STN1013001, Citicoline eye drops 2%, H-1337, OTX-TIC, LL-BMT1, TRS01, POLAT-001 (Liposomal latanoprost), Nyxol (Phentolamine Mesylate), QLS-101, BTQ-1902, VVN539, AGN-193408, and others
• The Open Angle Glaucoma epidemiology based on gender analyzed that women are predominantly affected by Open Angle Glaucoma (OAG) in the 7MM
• The Open Angle Glaucoma market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Open Angle Glaucoma pipeline products will significantly revolutionize the Open Angle Glaucoma market dynamics.

Open Angle Glaucoma Overview
If ignored, open-angle glaucoma (OAG), a common and dangerous eye ailment that damages the optic nerve, can result in blindness or visual loss. It is the most common type of glaucoma and usually progresses slowly over time, frequently with no symptoms at first. For this reason, it is also called the "silent thief of sight."

Get a Free sample for the Open Angle Glaucoma Market Report
https://www.delveinsight.com/report-store/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Open Angle Glaucoma Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Open Angle Glaucoma Epidemiology Segmentation:
The Open Angle Glaucoma market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Open Angle Glaucoma
• Prevalent Cases of Open Angle Glaucoma by severity
• Gender-specific Prevalence of Open Angle Glaucoma
• Diagnosed Cases of Episodic and Chronic Open Angle Glaucoma

Download the report to understand which factors are driving Open Angle Glaucoma epidemiology trends @ Open Angle Glaucoma Epidemiology Forecast
https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Open Angle Glaucoma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Open Angle Glaucoma market or expected to get launched during the study period. The analysis covers Open Angle Glaucoma market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Open Angle Glaucoma Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Open Angle Glaucoma Therapies and Key Companies
• NCX-470: Nicox Ophthalmics
• PDP-716 (Brimonidine Tartrate Ophthalmic Suspension): Sun Pharma Advanced Research Company Limited (SPARC)/Visiox Pharma
• TC-002 (latanoprost): TearClear
• iDose TR (Travoprost Intraocular Implant): Glaukos Corporation
• Sepetaprost/DE-126/ONO-9054/STN-1012600: Santen Inc/Ono Pharmaceutical
• Catioprost/DE-130A/STN1013001: Santen Pharmaceuticals
• Citicoline eye drops 2%: Omikron Italia S.r.l./OPIS Spain
• H-1337: D. Western Therapeutics Institute (DWTI)
• OTX-TIC: Ocular Therapeutix, Inc.
• LL-BMT1: MediPrint Ophthalmics (formerly Leo Lens Pharma)
• TRS01: Tarsier Pharma
• POLAT-001 (Liposomal latanoprost): Peregrine Ophthalmic
• Nyxol (Phentolamine Mesylate): Ocuphire Pharma
• QLS-101: Qlaris Bio, Inc.
• BTQ-1902: Betaliq, Inc.
• VVN539: VivaVision Biotech, Inc.
• AGN-193408: Abbvie

Discover more about therapies set to grab major Open Angle Glaucoma market share @ Open Angle Glaucoma Treatment Market
https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Open Angle Glaucoma Market Strengths
• Rising prevalence of Open Angle Glaucoma (OAG) resulting in demand for improved treatments. Growing awareness about the importance of early detection to reduce the disease burden contributes to increased screening and diagnosis rates

Open Angle Glaucoma Market Opportunities
• With increasing awareness and improving healthcare infrastructure, the Open Angle Glaucoma (OAG) market has growth potential in emerging markets

Scope of the Open Angle Glaucoma Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Open Angle Glaucoma Companies: Nicox Ophthalmics, Sun Pharma Advanced Research Company Limited (SPARC), Visiox Pharma, TearClear, Glaukos Corporation, Ono Pharmaceutical, Santen Pharmaceuticals, Omikron Italia S.r.l., OPIS Spain, D. Western Therapeutics Institute (DWTI), Ocular Therapeutix, Inc., MediPrint Ophthalmics (formerly Leo Lens Pharma), Tarsier Pharma, Peregrine Ophthalmic, Ocuphire Pharma, Qlaris Bio, Inc., Betaliq, Inc., VivaVision Biotech, Inc., Abbvie, and others
• Key Open Angle Glaucoma Therapies: , and others
• Open Angle Glaucoma Therapeutic Assessment: Open Angle Glaucoma current marketed and Open Angle Glaucoma emerging therapies
• Open Angle Glaucoma Market Dynamics: Open Angle Glaucoma market drivers and Open Angle Glaucoma market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Open Angle Glaucoma Unmet Needs, KOL's views, Analyst's views, Open Angle Glaucoma Market Access and Reimbursement

To know more about Open Angle Glaucoma companies working in the treatment market, visit @ Open Angle Glaucoma Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/open-angle-glaucoma-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Open Angle Glaucoma Market Report Introduction
2. Executive Summary for Open Angle Glaucoma
3. SWOT analysis of Open Angle Glaucoma
4. Open Angle Glaucoma Patient Share (%) Overview at a Glance
5. Open Angle Glaucoma Market Overview at a Glance
6. Open Angle Glaucoma Disease Background and Overview
7. Open Angle Glaucoma Epidemiology and Patient Population
8. Country-Specific Patient Population of Open Angle Glaucoma
9. Open Angle Glaucoma Current Treatment and Medical Practices
10. Open Angle Glaucoma Unmet Needs
11. Open Angle Glaucoma Emerging Therapies
12. Open Angle Glaucoma Market Outlook
13. Country-Wise Open Angle Glaucoma Market Analysis (2019-2032)
14. Open Angle Glaucoma Market Access and Reimbursement of Therapies
15. Open Angle Glaucoma Market Drivers
16. Open Angle Glaucoma Market Barriers
17. Open Angle Glaucoma Appendix
18. Open Angle Glaucoma Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Open Angle Glaucoma Pipeline https://www.delveinsight.com/report-store/open-angle-glaucoma-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
"Open Angle Glaucoma Pipeline Insight, 2023" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Open Angle Glaucoma market. A detailed picture of the Open Angle Glaucoma pipeline landscape is provided, which includes the disease overview and Open Angle Glaucoma treatment guidelines.
Open Angle Glaucoma Epidemiology https://www.delveinsight.com/report-store/open-angle-glaucoma-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Open Angle Glaucoma Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Open Angle Glaucoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Latest Reports by DelveInsight
Protein Supplements Market
https://www.delveinsight.com/report-store/protein-supplements-market
Protein Supplements Market By Source (Animal-Based [Whey, Casein, Fish, Eggs, Others], Plant-Based [Soy, Rice, Pea, Spirulina, Others]), By Product Type (Protein Powders, Protein Bars, Ready-To-Drink, And Others), By Application (Sports Nutrition And Functional Foods), By Distribution Channel (Supermarkets And Hypermarkets, E-Commerce, Direct-To-Consumer, Others), by geography is estimated to register growth at a remarkable CAGR forecast during 2022-2027 owing to the growing consumer awareness of having a protein rich diet,

Proteomics Market
https://www.delveinsight.com/report-store/prostate-cancer-market-insight
Proteomics Market By Product & Services (Instrumentation Technology [Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, And Other], Reagents & Consumables, And Software & Services), By Application (Clinical Diagnostics, Drug Discovery, And Others), By End-User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028.

Infrared Thermometer Market
https://www.delveinsight.com/report-store/infrared-thermometer-market
Infrared Thermometer Market By Product Type (Contact Thermometers And Non-Contact Thermometers), By End-User (Food And Beverage Industry, Electronic Industry, Healthcare Industry, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2028 owing to the growing need for robust temperature measuring devices in critical industries and rise in the number of infectious diseases across the globe.

Hemoglobinopathies Market
https://www.delveinsight.com/report-store/sport-nutrition-market
Hemoglobinopathies Market By Indication (Thalassemia, Sickle Cell Anaemia, And Others), By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2027 owing to the increasing prevalence of various hemoglobin disorders and the increasing research & developmental activities concerning to the hemoglobinopathies across the globe

Sport Nutrition Market
https://www.delveinsight.com/report-store/sport-nutrition-market
The Sports Nutrition Market By Product Type (Sports Drinks And Sports Supplements), By Distribution Channels (Hypermarkets & Supermarkets, E-Commerce, And Others), and by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing inclination toward following healthy and active lifestyle and growing importance of sports nutrition among athletes and sportspersons.

Endodontic Devices Market
https://www.delveinsight.com/report-store/endodontic-devices-market
Endodontic Devices Market By Product Type (Instruments [Apex Locators, Endodontic Motors, Endodontic Scalers, Endodontic Lasers, Handpieces, Machine-Assisted Obturation Systems, And Others], Consumables [Obturation, Access Cavity Preparation, Shaping And Cleaning]), By End-User (Dental Hospitals, Dental Clinics, And Others), and by geography is estimated to register growth at a remarkable CAGR during the forecast period from 2023-2028 owing to the rising patient pool associated with dental disorders, poor oral health, leading to increased number of root canal treatments, the increasing population opting for dental aesthetics, among others across the globe.

Chemotherapy Drugs Market https://www.delveinsight.com/report-store/chemotherapy-drugs-market
Chemotherapy Drugs Market By Drug Class (Alkylating Agents, Mitotic Inhibitors, Antimetabolites, Topoisomerase Inhibitors, And Others), By Indication (Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, And Others), By Route Of Administration (Oral And Parenteral), by geography is estimated to register growth at a remarkable CAGR forecast during 2023-2028 owing to increasing prevalence of different cancer types and increasing pharmaceutical trials for chemotherapy drugs.

Connected Drug Delivery Devices Market
https://www.delveinsight.com/report-store/connected-drug-delivery-devices-market
Connected Drug Delivery Devices Market By Product (Connected Sensors [Connected Inhaler Sensors And Connectable Injection Sensors] And Integrated Connected Devices [Connected Inhaler Devices And Connected Injection Devices], By Technology (Bluetooth, Near-Field Communication (NFC), And Others), By End-User (Healthcare Providers And Homecare), And by geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of chronic diseases such as diabetes and improving healthcare it infrastructure across the globe.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.